Tembexa
Product Images NDC 79622-012

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tembexa (NDC 79622-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chimerix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure of the active ingredient depicted in the Tembexa medication, showing molecular components with nitrogenous base, phosphate group, and a long hydrocarbon chain.*

FDA Label Image

Principal Display Panel (Oral Suspension Carton Label)

Label for Tembexa oral suspension, 10 mg/mL, manufactured by Chimerix, Inc. The label includes dosage instructions, storage conditions (20°C to 25°C), active ingredient (brincidofovir), and inactive ingredients. The package contains 65 mL and advises use of an oral dosing syringe. The label provides manufacturer contact information and warnings to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.